RT Journal Article
SR Electronic
T1 ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 396
OP 398
DO 10.1136/thoraxjnl-2020-215818
VO 76
IS 4
A1 Mandal, Swapna
A1 Barnett, Joseph
A1 Brill, Simon E
A1 Brown, Jeremy S
A1 Denneny, Emma K
A1 Hare, Samanjit S
A1 Heightman, Melissa
A1 Hillman, Toby E
A1 Jacob, Joseph
A1 Jarvis, Hannah C
A1 Lipman, Marc C I
A1 Naidu, Sindhu B
A1 Nair, Arjun
A1 Porter, Joanna C
A1 Tomlinson, Gillian S
A1 Hurst, John R
A1 
YR 2021
UL http://thorax.bmj.com/content/76/4/396.abstract
AB Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.